David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Halliburton
HAL
$28.7B
| $2.75M | ﹤0.01% |
+76,202
| New | +$2.93M |
|
2277
CALL
Axsome Therapeutics
AXSM
$10.9B
| $2.75M | ﹤0.01% |
34,600
| – | – |
|
2278
Magna International
MGA
$17.7B
| $2.75M | ﹤0.01% |
46,596
-73,504
| -61% | -$3.96M |
|
2279
PUT
American Eagle Outfitters
AEO
$2.95B
| $2.75M | ﹤0.01% |
130,000
| – | – |
|
2280
Thryv Holdings
THRY
$84.4M
| $2.75M | ﹤0.01% |
135,125
-58,840
| -30% | -$1.11M |
|
2281
Guidewire Software
GWRE
$15.9B
| $2.75M | ﹤0.01% |
25,207
-5,192
| -17% | -$495K |
|
|
DCBO
2282
Docebo
DCBO
$614M
| $2.74M | ﹤0.01% |
56,800
+7,800
| +16% | +$348K |
|
2283
Kontoor Brands
KTB
$4.22B
| $2.74M | ﹤0.01% |
43,878
+4,926
| +13% | +$253K |
|
2284
CALL
ChargePoint
CHPT
$154M
| $2.74M | ﹤0.01% |
58,500
+16,150
| +38% | +$903K |
|
2285
TETRA Technologies
TTI
$1.01B
| $2.73M | ﹤0.01% |
605,049
+19,686
| +3% | +$99.3K |
|
|
KNDI
2286
Kandi Technologies Group
KNDI
$66.1M
| $2.73M | ﹤0.01% |
975,691
-29,038
| -3% | -$89K |
|
2287
NetEase
NTES
$79B
| $2.73M | ﹤0.01% |
29,313
-29
| -0.1% | -$3.08K |
|
2288
PUT
Nabors Industries
NBR
$1.29B
| $2.73M | ﹤0.01% |
33,400
-27,600
| -45% | -$2.67M |
|
2289
Monro
MNRO
$394M
| $2.72M | ﹤0.01% |
92,652
-157,236
| -63% | -$4.42M |
|
2290
CALL
British American Tobacco
BTI
$124B
| $2.72M | ﹤0.01% |
+92,700
| New | +$2.82M |
|
2291
Prudential
PUK
$35.1B
| $2.71M | ﹤0.01% |
120,926
-275,208
| -69% | -$6.03M |
|
2292
Bank of N.T. Butterfield & Son
NTB
$2.32B
| $2.71M | ﹤0.01% |
84,700
+8,118
| +11% | +$230K |
|
2293
Oil States International
OIS
$500M
| $2.7M | ﹤0.01% |
397,878
+320,159
| +412% | +$2.32M |
|
2294
DHI Group
DHX
$193M
| $2.7M | ﹤0.01% |
1,043,064
-41,543
| -4% | -$107K |
|
2295
CALL
argenx
ARGX
$65.5B
| $2.7M | ﹤0.01% |
7,100
+4,900
| +223% | +$2.28M |
|
2296
PUT
Repligen
RGEN
$10.2B
| $2.7M | ﹤0.01% |
15,000
| – | – |
|
2297
Mercury Systems
MRCY
$5.4B
| $2.7M | ﹤0.01% |
73,723
-26,452
| -26% | -$955K |
|
2298
Lantheus
LNTH
$6.58B
| $2.69M | ﹤0.01% |
43,462
-127,894
| -75% | -$8.67M |
|
2299
Clover Health Investments
CLOV
$2.26B
| $2.69M | ﹤0.01% |
+2,830,048
| New | +$2.78M |
|
|
SUPV
2300
Grupo Supervielle
SUPV
$770M
| $2.69M | ﹤0.01% |
663,531
+334,561
| +102% | +$913K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.